$3.06 Billion is the total value of BRAIDWELL LP's 82 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | AVALO THERAPEUTICS INC | $0 | – | -247,254 | -100.0% | -0.01% | – | |
| IMTX | Exit | IMMATICS N.V | $0 | – | -322,287 | -100.0% | -0.07% | – |
| SILK | Exit | SILK RD MED INC | $0 | – | -63,331 | -100.0% | -0.08% | – |
| Exit | SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $0 | – | -6,500,000 | -100.0% | -0.22% | – | |
| TMDX | Exit | TRANSMEDICS GROUP INC | $0 | – | -98,459 | -100.0% | -0.25% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -24,600 | -100.0% | -0.30% | – |
| Exit | ARCELLX INC | $0 | – | -333,800 | -100.0% | -0.34% | – | |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -1,097,300 | -100.0% | -0.42% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -3,355,805 | -100.0% | -0.46% | – |
| STE | Exit | STERIS PLC | $0 | – | -95,694 | -100.0% | -0.60% | – |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -335,200 | -100.0% | -0.63% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -920,049 | -100.0% | -0.64% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -4,126,194 | -100.0% | -0.98% | – |
| Exit | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $0 | – | -36,533,000 | -100.0% | -1.12% | – | |
| AMGN | Exit | AMGEN INC | $0 | – | -161,500 | -100.0% | -1.29% | – |
| Exit | EXACT SCIENCES CORPnote 0.375% 3/1 | $0 | – | -48,300,000 | -100.0% | -1.49% | – | |
| Exit | NUVASIVE INCnote 1.000% 6/0 | $0 | – | -51,500,000 | -100.0% | -1.69% | – | |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -3,714,672 | -100.0% | -2.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 4 | Q3 2023 | 6.3% |
| EXACT SCIENCES CORP | 4 | Q3 2023 | 4.4% |
| NOVOCURE LTD | 4 | Q3 2023 | 3.9% |
| NANOSTRING TECHNOLOGIES INC | 4 | Q3 2023 | 4.0% |
| NEVRO CORP | 4 | Q3 2023 | 3.4% |
| BRIDGEBIO PHARMA INC | 4 | Q3 2023 | 3.5% |
| ALPHATEC HLDGS INC | 4 | Q3 2023 | 3.6% |
| GLAUKOS CORP | 4 | Q3 2023 | 3.0% |
| VAXCYTE INC | 4 | Q3 2023 | 2.8% |
| XENON PHARMACEUTICALS INC | 4 | Q3 2023 | 2.5% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.